$FONR
FONAR CORP Stock $fonr

$fonr Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000173112224001763 Filed on November 12, 2024

Income Statement

Concept	2024 Q3
Revenue	$24.96M
YoY Change	-3.4%
Cost Of Revenue	$14.92M
YoY Change	7.09%
Gross Profit	$10.04M
YoY Change	-15.61%
Gross Profit Margin	40.24%
Selling, General & Admin	$5.130M
YoY Change	5.43%
% of Gross Profit	51.08%
Research & Development	$307.0K
YoY Change	-34.26%
% of Gross Profit	3.06%
Depreciation & Amortization	$1.063M
YoY Change	-11.05%
% of Gross Profit	10.58%
Operating Expenses	$5.437M
YoY Change	1.95%
Operating Profit	$4.606M
YoY Change	-29.86%
Interest Expense	$644.0K
YoY Change	1241.67%
% of Operating Profit	13.98%
Other Income/Expense, Net	-$1.000K
YoY Change
Pretax Income	$5.249M
YoY Change	-25.33%
Income Tax	$1.249M
% Of Pretax Income	23.8%
Net Earnings	$3.135M
YoY Change	-23.65%
Net Earnings / Revenue	12.56%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.43
COMMON SHARES
Basic Shares Outstanding	6.304M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$54.33M
YoY Change	5.09%
Cash & Equivalents	$54.19M
Short-Term Investments	$136.0K
Other Short-Term Assets	$1.833M
YoY Change	41.0%
Inventory	$2.817M
Prepaid Expenses
Receivables	$80.12M
Other Receivables	$0.00
Total Short-Term Assets	$139.1M
YoY Change	7.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$19.54M
YoY Change	-7.42%
Goodwill	$4.269M
YoY Change	0.0%
Intangibles	$2.794M
YoY Change	-16.72%
Long-Term Investments
YoY Change
Other Assets	$6.850M
YoY Change	-26.34%
Total Long-Term Assets	$73.19M
YoY Change	1.08%
TOTAL ASSETS
Total Short-Term Assets	$139.1M
Total Long-Term Assets	$73.19M
Total Assets	$212.3M
YoY Change	5.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.082M
YoY Change	4.04%
Accrued Expenses	$6.490M
YoY Change	-12.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$48.00K
YoY Change	6.67%
Total Short-Term Liabilities	$14.43M
YoY Change	1.36%
LONG-TERM LIABILITIES
Long-Term Debt	$40.00K
YoY Change	-61.54%
Other Long-Term Liabilities	$38.27M
YoY Change	18.85%
Total Long-Term Liabilities	$39.04M
YoY Change	17.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.43M
Total Long-Term Liabilities	$39.04M
Total Liabilities	$53.46M
YoY Change	12.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.49M
YoY Change	-47.78%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.432M
YoY Change	16.42%
Treasury Stock Shares
Shareholders Equity	$168.7M
YoY Change
Total Liabilities & Shareholders Equity	$212.3M
YoY Change	5.33%

Cashflow Statement

Concept	2024 Q3
OPERATING ACTIVITIES
Net Income	$3.135M
YoY Change	-23.65%
Depreciation, Depletion And Amortization	$1.063M
YoY Change	-11.05%
Cash From Operating Activities	$1.657M
YoY Change	-36.71%
INVESTING ACTIVITIES
Capital Expenditures	$1.805M
YoY Change	2765.08%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.818M
YoY Change	2201.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.987M
YoY Change	-6.54%
NET CHANGE
Cash From Operating Activities	$1.657M
Cash From Investing Activities	-$1.818M
Cash From Financing Activities	-$1.987M
Net Change In Cash	-$2.148M
YoY Change	-620.1%
FREE CASH FLOW
Cash From Operating Activities	$1.657M
Capital Expenditures	$1.805M
Free Cash Flow	-$148.0K
YoY Change	-105.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q2	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	371000	usd
CY2024Q3	FONR	Accounts Payable Related Party Noncurrent AccountsPayableRelatedPartyNoncurrent	93000	usd
CY2024Q2	FONR	Accounts Payable Related Party Noncurrent AccountsPayableRelatedPartyNoncurrent	93000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	36970000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	37468000	usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	356000	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	395000	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	40000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	67000	usd
CY2024Q3	us-gaap	Other Liabilities OtherLiabilities	35000	usd
CY2024Q2	us-gaap	Other Liabilities OtherLiabilities	32000	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	39038000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	39601000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	53463000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	57458000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	180608000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	180608000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10489000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13624000	usd
CY2024Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	69000	shares
CY2023Q3	FONR	Product Sales Net ProductSalesNet	164000	usd
CY2024Q3	FONR	Service And Repair Fees Net ServiceAndRepairFeesNet	1992000	usd
CY2023Q3	FONR	Service And Repair Fees Net ServiceAndRepairFeesNet	1864000	usd
CY2024Q3	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	45000	usd
CY2023Q3	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	28000	usd
CY2024Q3	FONR	Management And Other Fees Net ManagementAndOtherFeesNet	12329000	usd
CY2023Q3	FONR	Management And Other Fees Net ManagementAndOtherFeesNet	12119000	usd
CY2024Q3	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	2987000	usd
CY2023Q3	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	2987000	usd
CY2024Q3	us-gaap	Revenues Revenues	24960000	usd
CY2023Q3	us-gaap	Revenues Revenues	25838000	usd
CY2024Q3	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	4646000	usd
CY2023Q3	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	4427000	usd
CY2024Q3	FONR	Costs Related To Product Sales CostsRelatedToProductSales	221000	usd
CY2023Q3	FONR	Costs Related To Product Sales CostsRelatedToProductSales	103000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	4106000	usd
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000355019
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	dei	Entity File Number EntityFileNumber	0-10248
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	FONAR CORPORATION
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-2464137
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	110 Marcus Drive
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Melville
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11747
CY2024Q3	dei	City Area Code CityAreaCode	631
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	694-2929
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Security12b Title Security12bTitle	Common Stock, $.0001 par value
CY2024Q3	dei	Trading Symbol TradingSymbol	FONR
CY2024Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	54193000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	56341000	usd
CY2024Q3	us-gaap	Short Term Investments ShortTermInvestments	136000	usd
CY2024Q2	us-gaap	Short Term Investments ShortTermInvestments	136000	usd
CY2024Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	3873000	usd
CY2024Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	4035000	usd
CY2024Q3	FONR	Account Receivable Related Parties AccountReceivableRelatedParties	90000	usd
CY2024Q2	FONR	Account Receivable Related Parties AccountReceivableRelatedParties	0	usd
CY2024Q3	FONR	Medical Receivable MedicalReceivable	23069000	usd
CY2024Q2	FONR	Medical Receivable MedicalReceivable	23992000	usd
CY2024Q3	us-gaap	Accrued Fees And Other Revenue Receivable AccruedFeesAndOtherRevenueReceivable	43569000	usd
CY2024Q2	us-gaap	Accrued Fees And Other Revenue Receivable AccruedFeesAndOtherRevenueReceivable	41954000	usd
CY2024Q3	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	9522000	usd
CY2024Q2	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	9865000	usd
CY2024Q3	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	2817000	usd
CY2024Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	2715000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1833000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1286000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	139102000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	140324000	usd
CY2024Q3	FONR	Accounts Receivable Net Long Term AccountsReceivableNetLongTerm	856000	usd
CY2024Q2	FONR	Accounts Receivable Net Long Term AccountsReceivableNetLongTerm	830000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	6357000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	7223000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19541000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18709000	usd
CY2024Q3	FONR	Note Receivable Related Party NoteReceivableRelatedParty	594000	usd
CY2024Q2	FONR	Note Receivable Related Party NoteReceivableRelatedParty	581000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	37803000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38428000	usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	481000	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	531000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	4269000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	4269000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2794000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2870000	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	493000	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	481000	usd
CY2024Q3	us-gaap	Assets Assets	212290000	usd
CY2024Q2	us-gaap	Assets Assets	214246000	usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	48000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	47000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1082000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1856000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5348000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7941000	usd
CY2024Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3758000	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3870000	usd
CY2024Q3	FONR	Unearned Revenue On Service Contracts Related Party UnearnedRevenueOnServiceContractsRelatedParty	82000	usd
CY2024Q2	FONR	Unearned Revenue On Service Contracts Related Party UnearnedRevenueOnServiceContractsRelatedParty	0	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3534000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3474000	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	227000	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	226000	usd
CY2024Q3	FONR	Customer Deposits CustomerDeposits	346000	usd
CY2024Q2	FONR	Customer Deposits CustomerDeposits	443000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14425000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	17857000	usd
CY2024Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1173000	usd
CY2024Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1175000	usd
CY2024Q3	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	371000	usd
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	45000	shares
CY2024Q3	us-gaap	Treasury Stock Value TreasuryStockValue	1432000	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1017000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	168688000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	165968000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	-9861000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	-9180000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	158827000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156788000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	212290000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	214246000	usd
CY2024Q3	FONR	Patient Fee Revenue Net Of Contractual Allowances And Discounts PatientFeeRevenueNetOfContractualAllowancesAndDiscounts	7487000	usd
CY2023Q3	FONR	Patient Fee Revenue Net Of Contractual Allowances And Discounts PatientFeeRevenueNetOfContractualAllowancesAndDiscounts	8676000	usd
CY2024Q3	FONR	Product Sales Net ProductSalesNet	120000	usd
CY2024Q3	FONR	Costs Related To Service And Repair Fees CostsRelatedToServiceAndRepairFees	1091000	usd
CY2023Q3	FONR	Costs Related To Service And Repair Fees CostsRelatedToServiceAndRepairFees	848000	usd
CY2024Q3	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	67000	usd
CY2023Q3	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	13000	usd
CY2024Q3	FONR	Costs Related To Management And Other Fees CostsRelatedToManagementAndOtherFees	7319000	usd
CY2023Q3	FONR	Costs Related To Management And Other Fees CostsRelatedToManagementAndOtherFees	7024000	usd
CY2024Q3	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	1573000	usd
CY2023Q3	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	1519000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	307000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	467000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5130000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4866000	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	20354000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	19267000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	4606000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	6571000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	8000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	48000	usd
CY2024Q3	FONR	Investment Income Related Party InvestmentIncomeRelatedParty	13000	usd
CY2023Q3	FONR	Investment Income Related Party InvestmentIncomeRelatedParty	0	usd
CY2024Q3	us-gaap	Investment Income Net InvestmentIncomeNet	639000	usd
CY2023Q3	us-gaap	Investment Income Net InvestmentIncomeNet	507000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5249000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7030000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1249000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1670000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	4000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	5360000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	865000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1254000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	3135000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156788000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156788000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	3135000	usd
CY2024Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	415000	usd
CY2024Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1546000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	865000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	158827000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	158827000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156788000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156788000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	4106000	usd
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	714000	usd
CY2023Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1401000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1254000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	154073000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	154073000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	4000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	5360000	usd
CY2024Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1063000	usd
CY2023Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1195000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1033000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1024000	usd
CY2024Q3	us-gaap	Premiums Receivable Allowance For Doubtful Accounts Recoveries PremiumsReceivableAllowanceForDoubtfulAccountsRecoveries	27000	usd
CY2023Q3	us-gaap	Premiums Receivable Allowance For Doubtful Accounts Recoveries PremiumsReceivableAllowanceForDoubtfulAccountsRecoveries	68000	usd
CY2024Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	866000	usd
CY2023Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1242000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	278000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2837000	usd
CY2024Q3	FONR	Increase Decrease In Notes Receivable IncreaseDecreaseInNotesReceivable	0	usd
CY2023Q3	FONR	Increase Decrease In Notes Receivable IncreaseDecreaseInNotesReceivable	5000	usd
CY2024Q3	FONR	Increase Decrease In Notes Receivable Related Party IncreaseDecreaseInNotesReceivableRelatedParty	-13000	usd
CY2023Q3	FONR	Increase Decrease In Notes Receivable Related Party IncreaseDecreaseInNotesReceivableRelatedParty	0	usd
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	102000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	255000	usd
CY2024Q3	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	547000	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-293000	usd
CY2024Q3	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	11000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-29000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-774000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-539000	usd
CY2024Q3	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2625000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1463000	usd
CY2024Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-796000	usd
CY2023Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1322000	usd
CY2024Q3	us-gaap	Increase Decrease In Trading Liabilities IncreaseDecreaseInTradingLiabilities	-37000	usd
CY2023Q3	us-gaap	Increase Decrease In Trading Liabilities IncreaseDecreaseInTradingLiabilities	-54000	usd
CY2024Q3	FONR	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	-98000	usd
CY2023Q3	FONR	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	20000	usd
CY2024Q3	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	3000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-12000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1657000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2618000	usd
CY2024Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1805000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	63000	usd
CY2024Q3	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	13000	usd
CY2023Q3	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	16000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1818000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-79000	usd
CY2024Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	26000	usd
CY2023Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	11000	usd
CY2024Q3	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock	415000	usd
CY2023Q3	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock	714000	usd
CY2024Q3	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1546000	usd
CY2023Q3	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1401000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1987000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2126000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2148000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	413000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	56341000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51280000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54193000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51693000	usd
CY2024Q3	FONR	Net Patient Fee Revenue NetPatientFeeRevenue	7487000	usd
CY2023Q3	FONR	Net Patient Fee Revenue NetPatientFeeRevenue	8676000	usd
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	128000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	128000	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	128000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	128000	shares
CY2024Q3	FONR	Net Income Loss Available To Common Stockholder Basic NetIncomeLossAvailableToCommonStockholderBasic	3135000	usd
CY2023Q3	FONR	Net Income Loss Available To Common Stockholder Basic NetIncomeLossAvailableToCommonStockholderBasic	4106000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6304000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6408000	shares
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.50
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.64
CY2024Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	3873000	usd
CY2024Q3	FONR	Accounts Receivable Net Related Party AccountsReceivableNetRelatedParty	90000	usd
CY2024Q3	us-gaap	Nontrade Receivables NontradeReceivables	23069000	usd
CY2024Q3	FONR	Management And Other Fees Non Related Parties ManagementAndOtherFeesNonRelatedParties	43569000	usd
CY2024Q3	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	9522000	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	4035000	usd
CY2024Q2	us-gaap	Nontrade Receivables NontradeReceivables	23992000	usd
CY2024Q2	FONR	Management And Other Fees Non Related Parties ManagementAndOtherFeesNonRelatedParties	41954000	usd
CY2024Q2	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	9865000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	856000	usd
CY2024	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	830000	usd
CY2024Q3	us-gaap	Contract Receivable Due One To Two Years ContractReceivableDueOneToTwoYears	693000	usd
CY2024Q3	us-gaap	Contract Receivable Due Two To Three Years ContractReceivableDueTwoToThreeYears	328000	usd
CY2024Q3	us-gaap	Contract Receivable Due Three To Four Years ContractReceivableDueThreeToFourYears	87000	usd
CY2024Q3	us-gaap	Contract Receivable Due Four To Five Years ContractReceivableDueFourToFiveYears	65000	usd
CY2024Q3	us-gaap	Accounts Receivable Billed For Long Term Contracts Or Programs AccountsReceivableBilledForLongTermContractsOrPrograms	1173000	usd
CY2024Q3	FONR	Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.67	pure
CY2023Q3	FONR	Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.67	pure
CY2024Q3	FONR	Percentage Of Consolidated Net Revenue From Management Fees PercentageOfConsolidatedNetRevenueFromManagementFees	0.120	pure
CY2023Q3	FONR	Percentage Of Consolidated Net Revenue From Management Fees PercentageOfConsolidatedNetRevenueFromManagementFees	0.116	pure
CY2024Q3	us-gaap	Other Inventory Supplies OtherInventorySupplies	2561000	usd
CY2024Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	2524000	usd
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	256000	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	191000	usd
CY2024Q3	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	2817000	usd
CY2024Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	2715000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	20328000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	20315000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	17534000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	17445000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2794000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2870000	usd
CY2024Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2708000	usd
CY2024Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4678000	usd
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	201000	usd
CY2024Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	197000	usd
CY2024Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	543000	usd
CY2024Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1461000	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	11000	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	11000	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	32000	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	120000	usd
CY2024Q3	us-gaap	Self Insurance Reserve SelfInsuranceReserve	177000	usd
CY2024Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	121000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	4000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	4000	usd
CY2024Q3	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	1672000	usd
CY2024Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	1349000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5348000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7941000	usd
CY2024Q3	us-gaap	Revenues Revenues	24960000	usd
CY2024Q3	FONR	Intersegment Net Revenues IntersegmentNetRevenues	289000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4606000	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1063000	usd
CY2024Q3	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1818000	usd
CY2023Q3	us-gaap	Revenues Revenues	25838000	usd
CY2023Q3	FONR	Intersegment Net Revenues IntersegmentNetRevenues	254000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	6571000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1195000	usd
CY2023Q3	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	79000	usd
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet	8000	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	48000	usd
CY2024Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	1301000	usd
CY2023Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	150000	usd
CY2024Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	359000	usd
CY2023Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1109000	usd
CY2024Q3	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	150000	usd
CY2024Q3	us-gaap	Self Insurance Reserve SelfInsuranceReserve	177000	usd
CY2024Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	121000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	1249000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	1249000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6357000	usd
CY2024Q3	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Policyholders Surplus DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus	371000	usd
CY2024Q3	FONR	Percentage Of Excise Tax PercentageOfExciseTax	0.01	pure
CY2024Q3	FONR	Corporate Alternative Minimum Tax Percentage CorporateAlternativeMinimumTaxPercentage	0.15	pure
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001731122-24-001763-index-headers.html	Edgar Link	pending
0001731122-24-001763-index.html	Edgar Link	pending
0001731122-24-001763.txt	Edgar Link	pending
0001731122-24-001763-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fonar_10-q.htm	Edgar Link	pending
fonar_exhibit-31.htm	Edgar Link	pending
fonar_exhibit-32.htm	Edgar Link	pending
fonar_logo.jpg	Edgar Link	pending
fonr-20240930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
fonar_10-q_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
fonr-20240930_cal.xml	Edgar Link	unprocessable
fonr-20240930_def.xml	Edgar Link	unprocessable
fonr-20240930_lab.xml	Edgar Link	unprocessable
fonr-20240930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FONR
FONAR CORP Stock $fonr

2024 Q3 Form 10-Q Financial Statement

#000173112224001763 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FONR FONAR CORP Stock $fonr

2024 Q3 Form 10-Q Financial Statement

#000173112224001763 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FONR
FONAR CORP Stock $fonr